Transcatheter Aortic Valve Implantation (TAVI)

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AT
1 program
cerebral embolic protectionN/A1 trial
Active Trials
NCT06962371RecruitingEst. Mar 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Ascend Therapeuticscerebral embolic protection

Clinical Trials (1)

NCT06962371Ascend Therapeuticscerebral embolic protection

Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)

Start: Apr 2025Est. completion: Mar 2026
N/ARecruiting

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space